Clinical Trial Update: Trigeminal Nerve Stimulation for Depression: Dose Finding [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluating trigeminal nerve stimulation for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of California, Los Angeles | Conditions: Depression | Phase 2 | Status: COMPLETED